Nevro's HFX iQ spinal cord stimulator earned the European Union's CE mark, the company said Nov. 12.

Kessler Foundation researchers published new findings on neuromodulation in individuals with high-level spinal cord injury ...

Nevro (NYSE:NVRO) announced today that it received CE mark in Europe for its HFX iQ spinal cord stimulation (SCS) system.

Inceptiv is a small device, implanted in the lower torso with leads to the spinal cord, that provides responsive counter-stimulation to relieve chronic pain. The device was approved by the FDA in ...

Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.

A pilot clinical trial led by University of Cincinnati researchers at the Lindner Center of HOPE found electrical stimulation of the spinal cord is feasible, well-tolerated and shows therapeutic ...

So, study lead author Dr. Francisco Romo-Nava designed a noninvasive spinal cord stimulation method that he has patented. Using this technology, he and his colleagues hoped to decrease the "noise" ...

A $2.5 million federal grant will fund a four-year study led by Kessler Foundation scientist Karen J. Nolan, PhD, to explore ...

Unfortunately, it leaves out an important evidence-based therapy option: electrical spinal cord stimulation (SCS). According to the current German S3-level Guideline on spinal cord stimulation ...

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer ...

New research shows that stimulation of the lumbosacral vertebrae region significantly elevated low blood pressure, unlike cervical or upper thoracic stimulation.

Kessler Foundation researchers published new findings on neuromodulation in individuals with high-level spinal cord injury (SCI) using spinal cord transcutaneous stimulation (scTS). This promising ...